05:47 PM EDT, 10/21/2025 (MT Newswires) -- P. Kent Hawryluk, Director, President & CEO, on October 20, 2025, executed a purchase for 20,000 shares in Mbx Biosciences ( MBX ) for $272,790. Following the Form 4 filing with the SEC, Hawryluk has control over a total of 949,674 common shares of the company, with 481,397 shares held directly and 468,277 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1776111/000119312525245411/xslF345X05/ownership.xml